Literature DB >> 21337262

Strategies adopted by late middle-age and older adults with HIV/AIDS to explain their physical symptoms.

Karolynn Siegel1, Helen-Maria Lekas, Eric W Schrimshaw, Courtney J Brown-Bradley.   

Abstract

Although the attributions individuals make about what causes their physical symptoms are known to influence their care seeking and self-care behaviours, much less is known about the strategies they use to arrive at these attributions. The strategies employed to understand the causes of their symptoms were investigated using in-depth interviews with 100 late middle-age and older adults with HIV/AIDS in New York City. The data revealed that most participants actively sought to explain their symptoms. The explanatory strategies identified included: relying upon illness or medication representations, lay beliefs about the body and ageing, invoking pre-existing vulnerabilities, engaging in lay experimentation, social comparison processes, considering temporal ordering and consulting authoritative sources. While most of them offered a single cause for their symptoms, some offered more complex multi-causal explanations. These findings provide understanding into the reasons why some older adults with HIV/AIDS misattribute symptoms resulting in delay in care or care over-utilisation, suggesting the need for patient education.

Entities:  

Keywords:  Causal attribution; HIV/AIDS; Illness representations; Older people; Symptom management

Mesh:

Year:  2011        PMID: 21337262      PMCID: PMC3111002          DOI: 10.1080/08870441003681299

Source DB:  PubMed          Journal:  Psychol Health        ISSN: 0887-0446


  38 in total

1.  More focus needed on symptom appraisal.

Authors:  Keith J Petrie; John Weinman
Journal:  J Psychosom Res       Date:  2003-05       Impact factor: 3.006

2.  Contribution of concrete cognition to emotion: neutral symptoms as elicitors of worry about cancer.

Authors:  D V Easterling; H Leventhal
Journal:  J Appl Psychol       Date:  1989-10

3.  Cultural diversity in causal attributions for illness: the role of the supernatural.

Authors:  H Landrine; E A Klonoff
Journal:  J Behav Med       Date:  1994-04

4.  Further explorations of common-sense representations of common illnesses.

Authors:  R R Lau; T M Bernard; K A Hartman
Journal:  Health Psychol       Date:  1989       Impact factor: 4.267

Review 5.  Beyond attentional strategies: cognitive-perceptual model of somatic interpretation.

Authors:  D Cioffi
Journal:  Psychol Bull       Date:  1991-01       Impact factor: 17.737

Review 6.  Explaining medically unexplained symptoms.

Authors:  Laurence J Kirmayer; Danielle Groleau; Karl J Looper; Melissa Dominicé Dao
Journal:  Can J Psychiatry       Date:  2004-10       Impact factor: 4.356

7.  Factors associated with HIV-infected women's delay in seeking medical care.

Authors:  V H Raveis; K Siegel; E Gorey
Journal:  AIDS Care       Date:  1998-10

8.  Common-sense models of illness: the example of hypertension.

Authors:  D Meyer; H Leventhal; M Gutmann
Journal:  Health Psychol       Date:  1985       Impact factor: 4.267

9.  Validation of a short Orientation-Memory-Concentration Test of cognitive impairment.

Authors:  R Katzman; T Brown; P Fuld; A Peck; R Schechter; H Schimmel
Journal:  Am J Psychiatry       Date:  1983-06       Impact factor: 18.112

10.  The causes of disease. Women talking.

Authors:  M Blaxter
Journal:  Soc Sci Med       Date:  1983       Impact factor: 4.634

View more
  2 in total

1.  Age, time living with diagnosed HIV infection, and self-rated health.

Authors:  J A McGowan; L Sherr; A J Rodger; M Fisher; A Miners; J Anderson; M A Johnson; J Elford; S Collins; G Hart; A N Phillips; A Speakman; F C Lampe
Journal:  HIV Med       Date:  2016-07-07       Impact factor: 3.180

2.  Association between HIV duration and symptom distress among middle-aged and elderly people with HIV-infected in China: a cross-sectional study.

Authors:  Meilian Xie; Aiping Wang; Kerong Wang; Yanping Yu; Zhaoxia Lin
Journal:  BMC Geriatr       Date:  2022-09-05       Impact factor: 4.070

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.